Poster Presentations at ASH 2022

Details of the poster presentations are as follows:

Title:	Molecular Biomarker Analyses for Exploring the Therapeutic Mechanism of Lemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)
Abstract ID:	3974
Presenter:	Prof. Chunkang Chang, Shanghai Sixth People’s Hospital
Session:	604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III
Location:	Ernest N. Morial Convention Center, Hall D
Date/Time:	Monday, December 12, 2022, 6:00 p.m. – 8:00 p.m. ET

Title:	Exploration of the Therapeutic Effects of CD47 and CD38 Antibody Combination in Relapsed or Refractory Multiple Myeloma
Abstract ID:	4462
Presenter:	Dr. Fanny Zhang, I-Mab
Session:	651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster III
Location:	Ernest N. Morial Convention Center, Hall D
Date/Time:	Monday, December 12, 2022, 6:00 p.m. – 8:00 p.m. ET